CliffBio
small molecule

OCALIVA

OBETICHOLIC ACID

Loss of exclusivityApril 2036latest FDA-listed patent expiry
CompanyIntercept Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameOCALIVA
Active ingredientOBETICHOLIC ACID
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2016
Marketing statusDISCN

Listed patents

PatentExpiresType
10052337April 2036product
10751349April 2036product
10758549April 2036use U-2945
10047117September 2033use U-1854
10174073June 2033substance
9238673June 2033product
RE48286February 2027substance, product

More from Intercept Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

OCALIVA patent cliff — loss of exclusivity April 2036 | CliffBio